In CP-North a highly qualified multidisciplinary team of researchers from all major Nordic countries will address a number of societal challenges associated with living with, or being a parent of a child, with a life-long disability in Norden by merging data from national registers with unique health data from quality registers.
Crohn's disease is a chronic inflammatory bowel disease. The biological drug Remicade is used in patients with Crohn's disease when normal treatment is inadequate. About one in three of the patients starting treatment with Remicade have sustained good effect over several years. However, serious side effects such as; infections, allergic reactions and concerns about long-term safety, with suspected increased risk of developing cancer, necessitate exploring strategies for when and in which patients to stop (discontinue) treatment again.
We hope to follow the temperature dependent exchange-coupling mechanism of the magnetic nanocomposite CoFe2O4/CoFe2 and to follow the sintering process of magnetic W-type Sr-hexaferrite in an effort to increase the magnetic properties.
The study of soft materials confined between surfaces is central to the understanding of interactions that lead to adhesion, lubrication and colloidal stability. Force measurements have long been able to describe the potential that exists between various coated surfaces, but it is only more recently that scattering techniques, particularly reflectometry, have permitted the detailed study of surface layers under confinement.
NordForsk awards funding to networks focusing on indigenous peoples in the Nordic region. The overall goal is to contribute to the sustainable and ethically sound development of communities and areas where indigenous peoples have interests.
The CAPE – Civic Agency in Public E-service innovation – project addresses these issues, regarding both improvement of current e-services, and releasing the potential in user-driven development of future services.
